MAR 25, 2019 10:09 AM PDT

Automated Drug Delivery System To Treat Post-Bariatric Hypoglycemia

WRITTEN BY: Nouran Amin

Low blood sugar is an increasing complication of patients who undergone weight-loss surgery known as post-bariatric hypoglycemia (PBH). The condition is characterized by a severe and debilitating low blood sugars after meals and if left untreated can result in seizures, loss of consciousness and death.

Learn more about gastric bypass complications:

Now, new research has developed an automated drug delivery system that can combat and prevent dangerously low blood sugar in weight-loss surgical patients. The research was presented at the 2019 Endocrine Society's annual meeting.

"Currently available treatments are not always effective for severely affected patients," said lead researcher Christopher M. Mulla, M.D. of Joslin Diabetes Center in Boston, Mass.

The automated drug delivery system is similar to an insulin pump and can detect decreasing glucose levels. They system will then deliver the hormone glucagon when levels are low to prevent hypoglycemic events.

"This study demonstrated that our glucagon automated delivery system can detect imminent low blood sugar and deliver a small dose of glucagon, yielding improvements in blood glucose levels after meals and reducing severe hypoglycemia in patients with PBH," Mulla said. "Further research and development of this system will help treat this challenging disease."

Source: Endocrine Society

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
SEP 17, 2020
Immunology
COVID Vaccine Works in Macaques - What about in Humans?
SEP 17, 2020
COVID Vaccine Works in Macaques - What about in Humans?
Pharmaceutical giant Pfizer, in partnership with BioNTech has reported that one of its lead vaccine candidates has shown ...
SEP 21, 2020
Microbiology
A Fast, Cheap Way to See if Two Antibiotics Work Together
SEP 21, 2020
A Fast, Cheap Way to See if Two Antibiotics Work Together
When a person has a bacterial infection, doctors can prescribe antibiotics. Some antibiotics combos can work better than ...
SEP 20, 2020
Drug Discovery & Development
New Drug Combo Prolongs Survival with Advanced Kidney Cancer
SEP 20, 2020
New Drug Combo Prolongs Survival with Advanced Kidney Cancer
Biopharmaceutical company Bristol-Myers Squibb has found that a new drug combination can reduce death rates among those ...
SEP 20, 2020
Drug Discovery & Development
Cholesterol-Lowering Drugs Reduce The Severity of COVID-19
SEP 20, 2020
Cholesterol-Lowering Drugs Reduce The Severity of COVID-19
Almost a year into the beginnings of the COVID-19 pandemic and we still do not have a Food and Drug Administration (FDA) ...
OCT 13, 2020
Drug Discovery & Development
Uses of Tandem Mass Spectrometry (TMS)
OCT 13, 2020
Uses of Tandem Mass Spectrometry (TMS)
What is tandem mass spectrometry? A powerful analytical tool that is capable of characterizing complex mixtures in drug ...
NOV 02, 2020
Drug Discovery & Development
Beetroot Peptide Shows Promise in Treating Inflammatory Diseases
NOV 02, 2020
Beetroot Peptide Shows Promise in Treating Inflammatory Diseases
Researchers from the Medical Univesity of Vienna in Austria have found that a peptide (a small protein molecule) found i ...
Loading Comments...